Differential toxicity of DNA adducts of mitomycin C
- PMID: 20798760
- PMCID: PMC2925095
- DOI: 10.4061/2010/698960
Differential toxicity of DNA adducts of mitomycin C
Abstract
The clinically used antitumor agent mitomycin C (MC) alkylates DNA upon reductive activation, forming six covalent DNA adducts in this process. This paper focuses on differential biological effects of individual adducts in various mammalian cell cultures, observed in the authors' laboratories. Evidence is reviewed that various adducts are capable of inducing different cell death pathways in cancer cells. This evidence is derived from a parallel study of MC and its derivatives 2,7-diaminomitosene (2,7-DAM) which is the main metabolite of MC and forms two monoadducts with DNA, and decarbamoyl mitomycin C (DMC), which alkylates and crosslinks DNA, predominantly with a chirality opposite to that of the DNA adducts of MC. Specifically, 2,7-DAM is not cytotoxic and does not activate the p53 pathway while MC and DMC are cytotoxic and able to activate the p53 pathway. DMC is more cytotoxic than MC and can also kill p53-deficient cells by inducing degradation of Checkpoint 1 protein, which is not seen with MC treatment of the p53-deficient cells. This difference in the cell death pathways activated by the MC and DMC is attributed to differential signaling by the DNA adducts of DMC. We hypothesize that the different chirality of the adduct-to-DNA linkage has a modulating influence on the choice of pathway. Future studies will be directed to elucidate mechanisms of MC- and DMC-DNA adduct signaling in a structure-dependent context.
Figures
Similar articles
-
Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.Chem Res Toxicol. 2008 Dec;21(12):2370-8. doi: 10.1021/tx8002615. Chem Res Toxicol. 2008. PMID: 19053323 Free PMC article.
-
Differential activation of p53 by the various adducts of mitomycin C.J Biol Chem. 2002 Oct 25;277(43):40513-9. doi: 10.1074/jbc.M205495200. Epub 2002 Aug 14. J Biol Chem. 2002. PMID: 12183457
-
Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C.Chem Res Toxicol. 2002 Nov;15(11):1398-406. doi: 10.1021/tx020044g. Chem Res Toxicol. 2002. PMID: 12437330
-
Insight Into Factors Governing Formation, Synthesis and Stereochemical Configuration of DNA Adducts Formed by Mitomycins.Chem Rec. 2023 Jan;23(1):e202200193. doi: 10.1002/tcr.202200193. Epub 2022 Oct 17. Chem Rec. 2023. PMID: 36251922 Review.
-
Mitomycin C: a prototype bioreductive agent.Oncol Res. 1994;6(10-11):501-8. Oncol Res. 1994. PMID: 7620218 Review.
Cited by
-
Synthesis of Oligonucleotides containing the cis-Interstrand Crosslink Produced by Mitomycins in their Reaction with DNA.Chemistry. 2020 Oct 1;26(55):12570-12578. doi: 10.1002/chem.202002452. Epub 2020 Sep 3. Chemistry. 2020. PMID: 32574396 Free PMC article.
-
Coordination between nucleotide excision repair and specialized polymerase DnaE2 action enables DNA damage survival in non-replicating bacteria.Elife. 2021 Apr 15;10:e67552. doi: 10.7554/eLife.67552. Elife. 2021. PMID: 33856342 Free PMC article.
-
Comparative Error-Free and Error-Prone Translesion Synthesis of N(2)-2'-Deoxyguanosine Adducts Formed by Mitomycin C and Its Metabolite, 2,7-Diaminomitosene, in Human Cells.Chem Res Toxicol. 2016 May 16;29(5):933-9. doi: 10.1021/acs.chemrestox.6b00087. Epub 2016 Apr 27. Chem Res Toxicol. 2016. PMID: 27082015 Free PMC article.
-
Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasome.Elife. 2023 Aug 2;12:e75628. doi: 10.7554/eLife.75628. Elife. 2023. PMID: 37530405 Free PMC article.
-
A skipping rope translocation mechanism in a widespread family of DNA repair helicases.Nucleic Acids Res. 2021 Jan 11;49(1):504-518. doi: 10.1093/nar/gkaa1174. Nucleic Acids Res. 2021. PMID: 33300032 Free PMC article.
References
-
- Hata T, Hoshi T, Kanamori K, et al. Mitomycin, a new antibiotic from Streptomyces. I. The Journal of Antibiotics . 1956;9:141–146. . - PubMed
-
- Carter SK, Crooke STE. Mitomycin C: Current Status and New Developments . New York, NY, USA: Academic Press; 1979. .
-
- Armstrong RW, Salvati ME, Nguyen M. Novel interstrand cross-links induced by the antitumor antibiotic carzinophilin/azinomycin B. Journal of the American Chemical Society . 1992;114(8):3144–3145. .
-
- Tomasz M, Lipman R, Chowdary D. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science . 1987;235(4793):1204–1208. . - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
